.jpg "Meghan Aversa, MD, MS, FRCPC photo")
Meghan Aversa, MD, MS, FRCPC
University Health Network
Jon Kobashigawa, MD
Cedars-Sinai Medical Center
Joseph Turek, MD, PhD
Duke Medical Center
Elaine Chou-Wu, PhD, F(ACHI)
Bloodworks NW
Adriana Zeevi, PhD
University of Pittsburgh Medical Center
Leaders in the field of thoracic transplantation will speak on cutting-edge procedures, discuss new and existing biomarkers, and describe current approaches to optimize outcomes for heart and lung transplant candidates. Furthermore, advances in the operating room procedures as well as post-transplant tools to monitor allograft health will be discussed. Additionally, new studies in lung transplantation that focus on approaches to overcome histocompatibility barriers and increase donor options for HLA sensitized candidates will be presented.
Session developed by Howie Gebel and Annette Jackson, program planning committee.
Speaker: Meghan Aversa, MD, MS, FRCPC – University Health Network
Speaker: Jon Kobashigawa, MD – Cedars-Sinai Medical Center
Speaker: Joseph Turek, MD, PhD – Duke Medical Center